Krebs Biochemicals & Industries (BOM:524518) Net Income From Continuing Operations : ₹-217.6 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Krebs Biochemicals & Industries's net income from continuing operations for the three months ended in Sep. 2024 was ₹-57.6 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-217.6 Mil.

Krebs Biochemicals & Industries Net Income From Continuing Operations Historical Data

The historical data trend for Krebs Biochemicals & Industries's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Net Income From Continuing Operations Chart

Krebs Biochemicals & Industries Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-288.72

-283.59

-445.27

-246.92

-197.28

Krebs Biochemicals & Industries Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-35.71	-49.77	-58.47	-51.71	-57.61

Krebs Biochemicals & Industries Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-217.6 Mil.

Krebs Biochemicals & Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

KREBSBIO:India

Address

Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031

Website

http://www.krebsbiochem.com

Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries Headlines

No Headlines